214 related articles for article (PubMed ID: 32253212)
1. Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model.
Bernhard F; Odedra R; Sordello S; Cardin R; Franzoni S; Charrier C; Belley A; Warn P; Machacek M; Knechtle P
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253212
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing
Johnson A; McEntee L; Farrington N; Kolamunnage-Dona R; Franzoni S; Vezzelli A; Massimiliano M; Knechtle P; Belley A; Dane A; Drusano G; Das S; Hope W
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253209
[No Abstract] [Full Text] [Related]
3.
Morrissey I; Magnet S; Hawser S; Shapiro S; Knechtle P
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988152
[TBL] [Abstract][Full Text] [Related]
4. Sigmoid
Knechtle P; Shapiro S; Morrissey I; De Piano C; Belley A
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0092621. PubMed ID: 34097479
[TBL] [Abstract][Full Text] [Related]
5. Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam.
Belley A; Morrissey I; Hawser S; Kothari N; Knechtle P
J Glob Antimicrob Resist; 2021 Jun; 25():93-101. PubMed ID: 33746112
[TBL] [Abstract][Full Text] [Related]
6. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an
VanScoy BD; Tenero D; Turner S; Livermore DM; McCauley J; Conde H; Bhavnani SM; Rubino CM; Ambrose PG
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947475
[TBL] [Abstract][Full Text] [Related]
8. In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model.
Gill CM; Abdelraouf K; Nicolau DP
J Antimicrob Chemother; 2021 Mar; 76(4):993-1000. PubMed ID: 33438033
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae.
Tselepis L; Langley GW; Aboklaish AF; Widlake E; Jackson DE; Walsh TR; Schofield CJ; Brem J; Tyrrell JM
Int J Antimicrob Agents; 2020 Jul; 56(1):105925. PubMed ID: 32084512
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of Cefepime Combined with Tazobactam against Clinically Relevant Enterobacteriaceae in a Neutropenic Mouse Thigh Model.
Melchers MJ; van Mil AC; Lagarde C; den Hartigh J; Mouton JW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630197
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia.
Das S; Fitzgerald R; Ullah A; Bula M; Collins AM; Mitsi E; Reine J; Hill H; Rylance J; Ferreira DM; Tripp K; Bertasini A; Franzoni S; Massimiliano M; Lahlou O; Motta P; Barth P; Velicitat P; Knechtle P; Hope W
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077666
[TBL] [Abstract][Full Text] [Related]
12. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
13. Multicenter surveillance of
Jean SS; Ko WC; Lu MC; Lee WS; Hsueh PR;
Expert Rev Anti Infect Ther; 2022 Jun; 20(6):941-953. PubMed ID: 34933656
[TBL] [Abstract][Full Text] [Related]
14. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
[TBL] [Abstract][Full Text] [Related]
16.
Abdelraouf K; Stainton SM; Nicolau DP
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061165
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates.
Morrissey I; Hawser S; Kothari N; Dunkel N; Quevedo J; Belley A; Henriksen AS; Attwood M
J Glob Antimicrob Resist; 2024 May; 38():71-82. PubMed ID: 38723712
[TBL] [Abstract][Full Text] [Related]
18. Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing
Shapiro S
Antimicrob Agents Chemother; 2022 May; 66(5):e0029822. PubMed ID: 35471043
[No Abstract] [Full Text] [Related]
19. An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
Isler B; Harris P; Stewart AG; Paterson DL
J Antimicrob Chemother; 2021 Feb; 76(3):550-560. PubMed ID: 33332545
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing
Vázquez-Ucha JC; Lasarte-Monterrubio C; Guijarro-Sánchez P; Oviaño M; Álvarez-Fraga L; Alonso-García I; Arca-Suárez J; Bou G; Beceiro A;
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0167621. PubMed ID: 34807754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
